Feinstein Kean Healthcare opens Denver office

DENVER: Feinstein Kean Healthcare, an Ogilvy PR subsidiary, will open a Denver office early next year to capitalize on the area's bio-tech market. Julie Murray, a director at Feinstein Kean, will head the new office and is already in Denver recruiting staff. The agency's clients in the area include Array, Ischemia and Genomia. Murray will also continue to serve West-Coast clients Pan Pacific Pharmaceuticals and Biomarin and oversee such accounts as Pfizer, Sepracor and Triangle Pharmaceuticals.

DENVER: Feinstein Kean Healthcare, an Ogilvy PR subsidiary, will open a Denver office early next year to capitalize on the area's bio-tech market. Julie Murray, a director at Feinstein Kean, will head the new office and is already in Denver recruiting staff. The agency's clients in the area include Array, Ischemia and Genomia. Murray will also continue to serve West-Coast clients Pan Pacific Pharmaceuticals and Biomarin and oversee such accounts as Pfizer, Sepracor and Triangle Pharmaceuticals.

DENVER: Feinstein Kean Healthcare, an Ogilvy PR subsidiary, will open a Denver office early next year to capitalize on the area's bio-tech market. Julie Murray, a director at Feinstein Kean, will head the new office and is already in Denver recruiting staff. The agency's clients in the area include Array, Ischemia and Genomia. Murray will also continue to serve West-Coast clients Pan Pacific Pharmaceuticals and Biomarin and oversee such accounts as Pfizer, Sepracor and Triangle Pharmaceuticals.

Feinstein Kean also will be pursuing Denver-area hospital, HMO and e-health accounts. The agency has annual billings in excess of dollars 9 million. The Denver office will be housed in Alexander Ogilvy and Ogilvy PR offices



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.